[1]
“New validated rp-hplc method for simultaneous estimation of lamivudine and tenofovir disproxil fumarate in tablets”, Int J of Adv in Phar Ana, vol. 5, no. 1, pp. 10–13, Feb. 2015, doi: 10.7439/ijapa.v5i1.1594.